| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |